Literature DB >> 16118512

Effects of unoprostone and endothelin 1 on L-type channel currents in human trabecular meshwork cells.

Hagen Thieme1, Kirsten Steinhausen, Anna Ottlecz, George N Lambrou, Olaf Strauss, Michael Wiederholt, Rita Rosenthal.   

Abstract

BACKGROUND: The trabecular meshwork (TM) is a smooth muscle-like tissue with contractile properties and by this mechanisms involved in the regulation of aqueous humor outflow. Isopropyl unoprostone (Rescula, Novartis Ophthalmics), a synthetic docosanoid, reduces intraocular pressure in glaucoma patients and normal subjects. In isolated TM strips, unoprostone reduces TM contractility in the presence of endothelin 1 (ET-1). However, the signal transduction pathway of unoprostone still remains unclear. Since L-type channel currents are known to influence the contractility of TM, we examined the effects of unoprostone and ET-1 on L-type channel currents of TM cells.
METHODS: The effects of unoprostone, ET-1 and the tyrosine kinase inhibitor herbimycin A on L-type channel currents of cultured human TM cells were investigated using the perforated patch configuration of the patch-clamp technique.
RESULTS: Application of ET-1 had no effect on L-type channel currents. Unoprostone led to a dose-dependent reduction of control currents. The effect of unoprostone is independent of ET-1. After preincubation of cells with herbimycin A, unoprostone had no effect on the L-type channel current amplitude. Human TM cells preincubated with herbimycin A showed a reduced current density compared with control cells. Both substances, unoprostone and herbimycin A, increased the inactivation time constant of L-type channel currents.
CONCLUSION: We conclude that unoprostone reduces the activity of L-type Ca2+ channels. This effect seems to be independent of ET-1. The signal transduction pathway seems to be mediated by tyrosine kinases. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16118512     DOI: 10.1159/000087724

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  6 in total

1.  Endogenous Bioactive Lipids and the Regulation of Conventional Outflow Facility.

Authors:  Zhou Wan; David F Woodward; W Daniel Stamer
Journal:  Expert Rev Ophthalmol       Date:  2008

Review 2.  Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.

Authors:  Carol B Toris; B'Ann T Gabelt; Paul L Kaufman
Journal:  Surv Ophthalmol       Date:  2008-11       Impact factor: 6.048

3.  Intraocular pressure reduction with once-a-day application of a new prostaglandin eye drop: a pilot placebo-controlled study in 12 patients.

Authors:  Ciro Caruso; Luigi Pacente; Pasquale Troiano; Carmine Ostacolo; Luca D'Andrea; Silvia Bartollino; Ciro Costagliola
Journal:  Int Ophthalmol       Date:  2019-12-03       Impact factor: 2.031

4.  Optogenetic stimulation of phosphoinositides reveals a critical role of primary cilia in eye pressure regulation.

Authors:  Philipp P Prosseda; Jorge A Alvarado; Biao Wang; Tia J Kowal; Ke Ning; W Daniel Stamer; Yang Hu; Yang Sun
Journal:  Sci Adv       Date:  2020-04-29       Impact factor: 14.136

5.  Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides.

Authors:  Scott D Smid
Journal:  Clin Ophthalmol       Date:  2009-12-29

Review 6.  An evidence-based review of unoprostone isopropyl ophthalmic solution 0.15% for glaucoma: place in therapy.

Authors:  Derrick S Fung; Jess T Whitson
Journal:  Clin Ophthalmol       Date:  2014-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.